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R-loop is a tri-nucleotide structure composed of DNA:RNA hybrid and non-template ssDNA. Tight 
regulation of R-loop formation is important for maintaining genomic stability. Abnormal R-loop 
formations are shown in some cancers and neurological disorders. Some of small molecules 
commonly used as DNA damaging reagents are discovered to regulate R-loop formation. For example, 
camptothecin (CPT), which induces DNA damage by inhibiting Topoisomerase I, enhances R-loop 
formation. To find out small molecules regulating R-loop formation, High Content Screening (HCS) 
to visualize R-loops in high-throughput manner was established. Baicalein was identified as the first 
small molecule reducing CPT-induced R-loops. Though it is still unclear whether baicalein directly 
binds to R-loop, R-loop reduction by baicalein depended on XPF. DNA damage marker, 53BP1 
recruitment to chromatin was decreased by baicalein treatment in XPF-dependent manner. However, 
the catalytic activity of XPF was dispensable for reduction of R-loop formation and 53BP1 
recruitment to chromatin by baicalein treatment. Collectively, I found a small molecule, baicalein, can 
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R-loop is one of the non-B DNA structure composed of RNA/DNA hybrid and associated non-
template single-stranded DNA. It is formed both in physiological and DNA damage condition. In the 
cellular process, R-loops are involved in the lagging-strand synthesis, DNA repair, regulation of gene 
expression, mitochondrial DNA replication, class-switch recombination in B cells and CpG-island 
promoter unmethylation. Due to the positive and negative effects of R-loop in cells, the formation of 
R-loop should be precisely regulated [1]. The disruption of this homeostasis can induce replication 
fork collapse and double strand breaks (DSBs) and potentially cause several neurological diseases and 
cancers [2, 3]. However, the exact molecular mechanism of R-loop resolution and the chemical that 
can regulate R-loop formation is not clearly understood since there are limited tools such as chemicals 
affecting R-loop formation. Therefore, I decided to find novel proteins and chemicals that affect R-
loop formation to understand pathological mechanisms driven by R-loop formation and potentially 
identify therapeutic approaches for R-loop related diseases. Recently, many DNA repair proteins were 
identified to function in R-loop formation suggesting some DNA repair pathways actively regulates 
R-loop formation.  
Many cancers are caused by some malfunctioning DNA repair mechanisms. Therefore, scientists are 
interested in linkage between DNA repair and cancer metabolism and search for small molecules 
targeting DNA repair [4]. For example, olaparib, which is a PARP1 inhibitor, is used for the treatment 
of BRCA-mutated ovarian cancer [5]. Baicalein (5, 6, 7-trihydroxy-2-phenyl-4H-1-benzopyran-4-one) 
is a flavone, which is a natural product extracted from the roots of Scutellaria baicalensis [6]. It 
affects diverse roles in biological activities such as a positive allosteric modulator of GABAA receptor 
[7], anti-cancer reagent [6], and antagonist of estrogen receptor [8]. In the recent study, the novel role 
of baicalein in DNA repair, especially in mismatch repair was revealed. Baicalein selectively kills 
mismatch repair deficient cells and binds preferentially with mismatched DNA and interacts with 
MSH2 and MSH6 proteins [9]. It has not been discovered whether baicalein can affect other bubble 
containing DNA structures. 
Nucleotide excision repair (NER) removes bulky DNA lesions from genome. There are two sub 
pathways of NER; global genomic NER (GG-NER) and transcription-coupled NER (TC-NER). TC-
NER resolve R-loop formation. (Figure 1, [10]). XPF is an 3’ to 5’ endonuclease of a NER lesion and 
functions to make a single strand break at 5’ end whereas XPG makes a single strand break at 3’ end 
of a bubble structure during TC-NER, respectively [11]. It has been reported that baicalein treatment 
induced 𝛾-H2AX formation in XPF dependent manner in mismatch repair deficient cells [9]. The 
molecular mechanism of XPF and baicalein has not been revealed so for. 
DSBs are mostly repaired by non-homologous end joining (NHEJ) repair and homologous 
recombination (HR). 53BP1 and BRCA1 drive NHEJ and HR, respectively [12, 13]. It has been 
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suggested that repair proteins in NER or mismatch repair (MMR) have a role in DSB repair [14, 15]. 
For example, XPF-ERCC1 complex is recruited by RAD52 on DSB and remove non-homologous 3’ 
single strand tails in alternative end-joining [16]. However, the direct relationship between 53BP1 and 
XPF/ERCC1 is still unknown. 
Here, I established screening methods using imaging and flow cytometry assay to find small 
molecules regulating R-loop. Among them, baicalein was found to decrease R-loop formation in the 
presence of XPF without affecting DSB efficiency. Also, my data exhibit a clue suggesting the 
relationship between XPF and 53BP1. 
 
 
Figure 1. Model of TC-NER (Transcription-coupled Nucleotide Excision repair) in 
transcription-replication conflict [10] 
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Materials and Methods 
1. DNA sequences used in SPR experiment and EtBr displacement assay 
Upstream DNA sequence : 5’-AGT GGT TCC CAT ATC CCG GAC GAG-3’, Upstream 
RNA sequence : 5’-AGU GGU UCC CAU AUC CCG GAC GAG-3’, Downstream DNA 
sequence : 5’-GGG ATC AGT GGT TCC CAT ATC CCG GAC GAG CCC CCA-3’ 
 
2. Antibodies 
S9.6 (Kerafast, ENH001, mouse), XPF 3F2/3 (Santacruz, sc-136153, mouse), XPF (NOVUS, 
NB100-60679, rabbit), RNASEH1 (Invitrogen, PA5-30974, rabbit), TOPOI C-21 (Santacruz, 
sc-32736, mouse), β-ACTIN (Sigma, 105M-4866V, mouse), 53BP1 (Abcam, ab21083, 
rabbit), BRCA1 (Santacruz, sc-6954, mouse), H2AX S139 (Sigma Aldrich, 05636, mouse), 
H3, pan (upstate, 07-690, rabbit), pATM S1981 (Abcam, ab81292, rabbit), mouse 
monoclonal phosphor-Histone H2AX (Ser139) (Millipore, #05-636) 
 
3. Plasmids 
HB-GFP was a gift from Dr. Kwangseog Ahn [17].  
 
4. Cell culture 
5. XP2YO cell lines were gifts from Dr. Schärer OD [18]. HeLa, U2OS, and XP2YO cell lines 
were cultured in DMEM (HyCloneTM) with 1xPen-Sterp supplemented by 10% fetal bovine 
serum (FBS). All cell lines were cultured in humid incubator with 5% CO2 at 37°C. 
 
6. R-loop staining 
R-loops was stained with S9.6 antibody. Cells were harvested and treated with hypotonic 
solution (75 mM KCl). Cells were then fixed on clean glass slides by methanol. After 
blocking for 1 hour with blocking solution (5% BSA and 0.5% Triton X-100), the fixed cells 
were subjected to stain with S9.6 antibody. 
 
7. Immunofluorescence 
Cells were seeded 24hours before the treatment of small molecules. Cells were then washed 
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with ice-cold PBS. Cells were permeabilized using cytoskeletal (CSK) buffer (10 mM PIPES 
(pH 6.8), 100 mM NaCl, 300 mM Sucrose, 3 mM MgCl2, 1 mM EGTA (pH 7.5)) with 0.5% 
Triton X-100. For S9.6 antibody, 0.5% of Triton X-100 in PBS was used for permeabilization 
instead of CSK buffer. Cells were washed and fixed with 4% of paraformaldehyde for 20 
minutes in dark condition and following incubation for blocking with 10% FBS at room 
temperature for 1 hour. The fixed cells were subjected to stain with indicated antibodies for 
over-night at 4°C. Cells were then incubated with fluorescence-conjugated second antibodies 
(Invitrogen) and mounted with permanent mounting medium with DAPI (Vector Labs). 
 
8. Chromatin fractionation 
Soluble form of the cells was extracted using M-PERTM (Thermo Fisher) with 1X benzonase. 
The chromatin-bound fraction was isolated by resuspending the insoluble pellet by RIPA 
buffer (150 mM NaCl, 1 % NP-40 or Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 
50 mM Tris (pH 8.0), 10 mM NaF, 1 mM Na3VO4, and protease inhibitors (Roche)) on ice 
for 30 minutes followed by sonication and centrifugation. 
 
9. Western blot analysis 
To extract whole proteins in cells, cells were lysed by M-PER (Thermofisher) with 
phosphatase and protease inhibitor cocktail (Thermofisher) at 4°C. The amount of proteins 
was quantified with Bradford assay (Bio-Rad). 4-20% of Invitrogen gradient gel and MES 
buffer were used for separation of proteins by their sizes. Proteins in gel were transferred to 
polyvinylidene difluoride (PVDF) membrane in Tris-glycine buffer (Bio-Rad) with 20% of 
methanol by electrical current. Chemidoc (Bio-Rad) was used to obtain Western blotting 
images.  
 
10. EtBr displacement assay 
Fluorescence of EtBr was recorded in Synergy HTX Microplate Reader at excitation and 
emission wavelengths of 485nm and 612nm respectively. Each sample contained 100ng of 
either double strand DNA (dsDNA) or DNA:RNA hybrid with 6.43 μM of EtBr. 0.2 mM, 0.4 
mM, 0.8 mM of netropsin, baicalein, or CPT was added in samples and calculated using the 
following equation. 
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Percentage of relateive fluroescence =
(𝐹𝑜𝑏𝑠 − 𝐹0) × 100
(𝐹𝐷𝑁𝐴 − 𝐹0)
 
𝐹0, 𝐹𝐷𝑁𝐴, 𝐹𝑜𝑏𝑠 are the fluorescence intensities of unbound EtBr, EtBr intercalated with 
DNA and EtBr-DNA complex with small molecules respectively. 
 
11. Proximity ligation assay 
PLA was done with Duolink® PLA fluorescence protocol (Sigma Aldrich). Cells were 
washed with PBS and incubated with CSK buffer at 4°C for 10 minutes. Cells were then 
fixed with 4% paraformaldehyde for 20 minutes at room temperature and blocked with 10% 
of PBS for an hour at 37°C. S9.6, XPF, and 53BP1 antibodies were incubated for overnight 
at 4°C. Three times wash with PLA wash buffer A was done before addition of Duolink® 
antibody diluent. Ligation, amplification and washing with wash buffer B were done as in 
the protocol. Cells were mounted with mounting solution and put on the coverslips. 
 
12. Colony forming assay 
Cells were seeded after treatment of DNA damaging reagents. After 14 days of incubation, 
survived colonies were washed with PBS and stained with 2 ml of methylene blue for 5 
minutes at RT. The plates were rinsed with tap water and air-dried for few days. Colonies 
were counted with a stereomicroscope and plating efficiency (PE) and surviving fraction 
(SntsF) were calculated. 
PE =
(𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 𝑓𝑜𝑟𝑚𝑒𝑑)
(𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑠𝑒𝑒𝑑𝑒𝑑)
 × 100% 
SF =
(𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 𝑓𝑜𝑟𝑚𝑒𝑑 𝑎𝑓𝑡𝑒𝑟 𝑑𝑎𝑚𝑎𝑔𝑒 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡)
(𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑠𝑒𝑒𝑑𝑒𝑑)
× 100%  
 
13. Cell cycle analysis 
Cells were harvested and washed with PBS. Pellets were fixed in ice-cold 70% ethanol and 
incubated at 4°C for at least 1hour. Washed cells with PBS for 2 times were collected by 
centrifugation at 850 g. Cells were resuspended with PBS diluted propidium iodide (PI) 
before analysis of cell cycle by FACSVerse. 
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14. Sample preparation for flow cytometry 
Cells were harvested with trypsin and washed with PBS. Pellets were incubated in PBS-T 
(0.2% Triton X-100) at 4°C for 10 minutes. Cells then washed with 2% of FBS and incubated 
at 4°C for 20 minutes with BD cytofix/cytoperm buffer (BD Bioscience). BD perm/wash 
buffer (BD Bioscience) was used for washing. Samples were incubated with RPA antibody 
diluted in BD perm/wash buffer at RT for 2 hours. After wash twice with BD perm/wash 
buffer, Alexa-488 Donkey-anti-rabbit antibody diluted in BD perm/wash buffer was added 
for 20 minutes at 4°C. Samples were washed with BD perm/wash buffer. PI (0.2 μg/ml) and 
RNaseA (10 μg/ml) were added before analysis of fluorescence by FACSVerse. 
 
15. High Content Screening (HCS) 
Cells were seeded in SCREENSTAR 96-well plates (Greiner) and treated with small 
molecules before staining with S9.6 antibody. HCS was performed with ImageXpress Micro 
XLS. 16 images per well were acquired for both channels at 20X magnification. Images were 







Screening small molecules regulating R-loop formation 
ATAD5 forms a Replication Factor C (RFC) Like Complex (RLC) and unloads PCNA during DNA 
replication [19]. Since ATAD5 stabilizes in response to DNA replication stresses, a HEK293T cell line 
expressing luciferase fused ATAD5 (ATAD5-luc) was established to detect DNA replication stress 
[20]. Previously, our laboratory used ATAD5-luc HEK293T cells to identify small molecules 
enhancing DNA replication stresses and found ~300 compounds. Since accumulated R-loop could 
cause replication stress and many DNA repair proteins might contribute to regulating R-loop 
formation, I hypothesized that identified small molecules would regulate R-loop formation. To 
establish R-loop detection with treatment of small molecules, CPT, which is a well-known R-loop 
inducing compound by inhibiting topoisomerase I, was employed to optimize R-loop detection 
method. I set up imaging and flow-cytometry methods for R-loop detection. R-loop detection by 
imaging was established with S9.6 antibody with confocal microscope (Figure 2A, B). Increased level 
of R-loop upon CPT treatment was established with imaging method (Figure 2A). Many R-loops were 
formed in the nucleolin which is consistent to the previous report (Figure2B, [21]). After checking 
CPT-induced R-loop formation with confocal microscope, the level of R-loop with CPT treatment 
was check using MetaXpress. The intensity of S9.6 increased with CPT treatment in concentration 
dependent manner and it peaked at 10 μM of CPT treatment (Figure 2C, D). HB-GFP can indirectly 
detect R-loops in vivo [22] since HB-GFP binds to R-loop without resolving R-loop structure. I 
successfully detected R-loop with HB-GFP after CPT treatment (Figure 3A). In flow cytometry 
analysis, HB-GFP was used to indirectly mark the R-loop. The level of R-loop peaked at 15 minutes 
of 5 μM CPT treatment (Figure 3B). 
 
Baicalein reduces CPT-induced R-loop formation 
Baicalein is a type of flavonoid and it is an analogue of baicalin [23] (Figure 4a). Recently, my 
colleague also found that mismatch repair proteins, MSH2-MSH3 function at the early step of 
homologous recombination (Oh et al., unpublished results). Since MSH2 and baicalein interacts each 
other, I hypothesized that baicalein could enhance cellular toxicity caused by different DSB inducing 
DNA damaging agents. I tested CPT, etoposide or ionizing radiation, which induce DNA DSBs by 
inhibiting topoisomerase I, II, or energy transfer, respectively [24, 25]. Baicalein treatment together 
with CPT showed synergistic cellular death, which was not observed by etoposide or IR treatment 
(Figure 4b). CPT is a well-known DNA damage reagent by inhibiting topoisomerase I and also known 
to increase R-loop formation [26]. Therefore, I checked whether R-loop formation enhanced by CPT 
treatment is affected by co-treatment of baicalein. The level of R-loop was decreased upon co-
treatment of baicalein and CPT compared to CPT treatment alone (Figure 4c, d). Consistent with the 
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R-loop formation, the level of RPA was also decreased when CPT was treated together with baicalein 
compared to CPT treatment alone. R-loops are mainly generated when transcription and replication 
collided each other. Thus, higher R-loop formation could result in S-phase delay [27]. However, co-
treatment of baicalein and CPT did not show any significant change of S-phase population compared 
to CPT treatment alone (Figure 5a). Further FACS experiment checking delay of S-phase should be 
done with G1 phase arrest.  
 
Baicalein didn’t strongly bind to DNA:RNA hybrid 
Baicalein preferentially binds to mismatched dsDNA than to unmodified DNA [9]. Mismatched base 
pairs in dsDNA can form bubble structure [28], and R-loops also mimics bubble DNA structure [29]. 
Before checking whether baicalein can bind to R-loop structure, I checked whether baicalein 
preferentially bind to DNA:RNA hybrid. However, I could not detect preferential interaction of 
baicalein with DNA:RNA hybrid compared to double stranded DNA (Figure 6a, b). I will investigate 
whether baicalein preferentially interact with R-loop structure compared to normal DNA structure.  
 
R-loop is resolved by baicalein in XPF dependent manner 
It was recently reported that baicalein induced 𝛾-H2AX in mismatch repair deficient cells in XPF 
dependent manner [9]. Therefore, I hypothesized that XPF could function to reduce CPT-induced R-
loop formation upon baicalein treatment. To test the hypothesis, I monitored the R-loop formation in 
XPF deficient cells in various treatment conditions with CPT and baicalein. The R-loop was increased 
with baicalein treatment with CPT in XPF deficient cells, whereas baicalein treatment with CPT 
significantly decreased the formation of R-loop formation in XPF complemented cells (Figure 7a, b). 
Surprisingly, the nuclease activity-dead mutant of XPF (D687A) rescued the level of R-loop 
formation upon both baicalein and XPF treatment similar to wild type complemented cells (Figure 7a, 
b). Therefore, I concluded that baicalein regulates the CPT-induced R-loop formation in XPF 
dependent manner but nuclease activity of XPF is dispensable (Figure 7c).  
 
XPF is important to recruit 53BP1 to the chromatin by baicalein 
NHEJ and HR are predominant repair pathways for DSBs and determinants of each pathway are 
accumulation of 53BP1 at DSB sites and recruitment of BRCA1, respectively [12, 13]. Since 
unproperly resolved R-loops can lead to DSBs [2, 3], the increased level of 𝛾-H2AX and 53BP1 were 
monitored. The level of 𝛾-H2AX and 53BP1 on chromatin enhanced by CPT was reduced upon 
baicalein treatment (Figure 8a). Consistently, the intensity of both 𝛾-H2AX and 53BP1 nuclear foci 
was decreased upon baicalein and CPT treatments compared to CPT treatment alone (Figure 8b, c). 
However, the level of 𝛾-H2AX and 53BP1 was further increased by baicalein and CPT co-treatment 
in in XPF deficient cells (Figure 8a). Consistently, immunoblotting of 𝛾-H2AX and 53BP1 showed 
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similar results (Figure 8b, c). Collectively, 53BP1 recruitment to the chromatin and the enhanced level 
of 𝛾-H2AX by CPT treatment are reduced by baicalein treatment in XPF dependent manner. 
 
Catalytic activity of XPF is dispensable for 53BP1 recruitment to the chromatin by baicalein 
Nuclease activity of XPF is important to function in DNA damage repair [30]. To validate if nuclease 
activity of XPF is important to resolve R-loop with baicalein, I used cells expressing XPF catalytic 
dead-mutant: D687A in patient derived XPF-deficient cells. XPF catalytic-dead mutant rescued the 
level of R-loop formation upon both baicalein and CPT treatment similar to wild type XPF (Figure 7a, 
b). Therefore, I checked whether XPF catalytic-dead mutant could also rescue the level of 𝛾-H2AX 
and 53BP1 upon baicalein and CPT co-treatment in an XPF dependent manner by Western blotting 
and immunostaining. 53BP1 recruitment to chromatin was decreased upon baicalein treatment alone 
or with CPT treatment in XPF nuclease dead mutant cells. Surprisingly, similar to XPF WT, XPF 
mutant didn’t have significant difference in the level of 𝛾-H2AX upon treatment of CPT alone or CPT 
and baicalein. The level of 53BP1 also rescued the level of protein on chromatin by Western blot 
analysis (Figure 9a). The level of 53BP1 also rescued in XPF catalytic mutant cell lines in 
immunostaining data (Figure 9b, c). In conclusion, nuclease activity of XPF is not important for 
53BP1 recruitment to chromatin upon baicalein treatment. Therefore, I will analyze if XPF is able to 









Baicalein synergistically induces cell death with CPT (Figure 4A). Since I only checked the level of 
R-loop formation by baicalein and CPT, I will analyze the R-loop formation by baicalein with other 
DNA damaging reagents. 
NER is divided in to two sub pathways: GG-NER and TC-NER depending on the transcriptional 
activity of the chromosome [31]. Two nucleases XPF and XPG both work in GG-NER and TC-NER 
[11]. To validate the effect is specific on XPF or NER including both TC-NER and global NER, I will 
compare the R-loop formation in other NER protein, XPG deficient cells. 
XPF can either work with XPA in NER or with SLX4 in the interstrand cross linking (ICL) repair. To 
further distinguish the effect is limited to NER or ICL, I will compare the R-loop formation in XPA 
deficient cells and SLX4 deficient cells. 
To elucidate molecular mechanism how baicalein reduces CPT-induced R-loop formation and 53BP1 
recruitment to chromatin in the XPF dependent manner, I need further following studies. First, I have 
to check the interaction between R-loop and XPF, R-loop and 53BP1 and XPF and 53BP1. I am going 
to investigate those interactions with Proximity Ligation assay (PLA), which can see the interaction 
between proteins. Also, there is no report that 53BP1 is linked to R-loop formation. R-loop formation 
in 53BP1 deficient condition will be investigated. 
Baicalein binds to mismatched DNA preferentially. dsDNA having mismatched base pairs got bubble 
structure [9]. It seemed that baicalein could have binding affinity to bubble structures in R-loop 
structure. I am planning to conduct an experiment using SPR system to verify the interaction between 









Discussion & Conclusion 
 
Regulation of R-loop formation should be tightly regulated as their integrity is involved in DNA 
damage, transcription and a lot of cellular function. Emerging studies of R-loop are focused on novel 
protein regulating R-loop formation. Small molecules inducing DNA damage can enhance abnormal 
R-loop formation. Since, dysregulation of R-loop formation in damage condition could increase 
genomic instability and potentially tumorigenesis, comprehensive understanding of R-loop formation 
and small molecules affecting R-loop formation would be beneficial to cancer patients. In this study, I 
found that baicalein can regulate R-loop formation without affecting the level of 𝛾-H2AX (Figure 4c, 
d, Figure 8a, b, c). Baicalein regulates R-loop formation in XPF dependent manner. However, the 
catalytic activity of XPF appears not to be important for R-loop regulation (Figure 8A, B). Further 
functional study of XPF in R-loop with baicalein would reveal unknown function of XPF. There are 
several SLX4 mutations found in patients defective in XPF interaction [32]. It would be interesting to 
investigate whether R-loop regulation by XPF requires SLX4 interaction. Those mechanistic studies 
would verify the importance of XPF in R-loop formation. 
53BP1 recruitment to chromatin was decreased by baicalein and it also seemed to depend on XPF 
(Figure 8a, b, c). The relationship between 53BP1 and XPF is not revealed and even whether 53BP1 
has role in R-loop formation or not is not discovered so far. Study validating the direct mechanism 
between 53BP1 and XPF would discover novel mechanism of R-loop. Checking the relationship 
between 53BP1 and R-loop would contribute to reveal the role of novel DNA damage repair proteins 
in R-loop formation. It could unveil the potential role of NHEJ pathway in R-loop regulation.  
DNA damaging agent, CPT is commonly prescribed to cancer patients [25]. Patients with CPT-
resistant cancers are prescribed CPT with other DNA toxins or irradiation therapy (CPT-resistance 
and additional therapy). Small molecules identified in following studies will benefit to CPT-resistant 
cancer patients. Furthermore, small molecules regulating R-loop formation can be the key for tumor 
patients having resistant to typical chemical treatment. 
Most of the R-loop studies are focused on R-loops formed in cellular stress such as replication-
transcription collision and DNA damage repair [1, 3]. Since R-loop formation is important for cellular 
processes [1-3], R-loops formed in non-DNA damage conditions should be studied. For most of the 
small molecules regulating R-loop formation induce DNA damage, further studies distinguish R-loop 

















Figure 2. Setting up HCS method using CPT as a positive control.  
(a) 20X confocal image stained with S9.6 antibody. (b) 40X confocal image stained with S9.6 






Figure 3. HB-GFP can be used as complementary method for R-loop screening.  
















Figure 4. Baicalein reduced the CPT-induced R-loop formation.  
(a) Structure of baicalein (b) Colony forming assay to check the viability upon damage inducing 
reagents treatment with baicalein treatment. Co-treatment of CPT and baicalein further reduced the 
survival rate of U2OS. (** : P<0.005) (c) Representative image of R-loop formation upon either 
baicalein or CPT treatment. R-loop was detected with S9.6 antibody. (d) Quantitative graph of (c). 
The intensity of total foci was analyzed with One-way ANOVA. (n=3, **** : P<0.0001) (e) The level 
of chromatin bound RPA was significantly reduced when baicalein was treated in CPT-treated U2OS 




Figure 5. Baicalein didn’t affect cell cycle.  
(a) Cell cycles upon treatment of either baicalein or CPT are indicated. PI was used to quantify the 















Figure 6. Baicalein doesn’t preferentially bind to DNA:RNA hybrid.  
(a) SPR system was used to check the interaction between baicalein and dsDNA or DNA:RNA hybrid. 
















Figure 7. Baicalein reduced the CPT-induced R-loop formation in an XPF dependent manner.  
(a) Representative image of R-loop formation upon either baicalein or CPT was detected with S9.6 
antibody. (b) Quantitative data of (a). The intensity of total foci was analyzed with one-way ANOVA. 
(n=3, * : P<0.05, ** : P<0.005, *** : P<0.0005, **** : P<0.0001) (c) Model of baicalein regulating 






Figure 8. Baicalein reduces the 53BP1 recruitment in an XPF dependent manner.  
(a) Chromatin bound 53BP1 are shown upon baicalein or CPT treatment. (b) Representative image of 
R-loop formation upon either baicalein or CPT was measured with S9.6 antibody. (c) Quantitative 
data of (b). The intensity of total foci was analyzed with One-way ANOVA. (n=3, *** : P<0.0005, 



































Figure 9. Catalytic activity of XPF is dispensable for recruiting 53BP1 by baiclaein.  
(a) Representative image of R-loop formation upon either baicalein or CPT was measured with S9.6 
antibody. (b) Quantitative data of (a). (c) Quantitative data of (b). The intensity of total foci was 
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